In patients with PAH, reducing peripheral serotonin using rodatristat ethyl negatively affects pulmonary hemodynamics and cardiac function.

Tectonic's lead asset, TX45, is a long-acting Fc-relaxin fusion protein to treat group 2 pulmonary hypertension. Read why I'm ...

Researchers also find that patients with penicillin allergy labels were more likely to get broad-spectrum antibiotics and ...

Pakistan has 3 new wild poliovirus type 1 infections, while the DR Congo and South Sudan report more vaccine-derived cases.

HOMA-IR z-scores were associated with increased risks for incident lung disease, interstitial lung abnormalities, and ...

In patients with familial PAH, SMAD5 appears to be a novel gene that warrants consideration for genetic testing, according to ...

Dasatinib is under clinical development by Bristol-Myers Squibb and currently in Phase II for Non-Small Cell Lung Cancer.

Ponatinib hydrochloride is under clinical development by Takeda Pharmaceutical and currently in Phase II for Non-Small Cell Lung Cancer.

Increasing average concentrations of sotatercept improved 6-minute walk distance, pulmonary vascular resistance, and levels ...

seat cushion Overview of the top 35 therapies under development against COVID-19 What's new about Down syndrome? Sotatercept for improving pulmonary vascular resistance received FDA breakthrough ...

INR:8341. praful patel Sotatercept for improving pulmonary vascular resistance received FDA breakthrough therapy designation Antengene's ATG-010 registration clinica ...